Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 28 Article 4
Back to Table of Contents
Previous

Eurosurveillance, Volume 7, Issue 28, 10 July 2003
Articles

Citation style for this article: WHO announces worldwide containment of SARS. Euro Surveill. 2003;7(28):pii=2254. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2254

WHO announces worldwide containment of SARS

Editorial team (eurowkly@hpa.org.uk), Eurosurveillance editorial office.

Taiwan, the last country remaining on the World Health Organization (WHO) list of countries with local SARS transmission, was this week removed from the list, signalling the global containment of the epidemic (1,2). It has been over 20 days, or two consecutive 10-day incubation periods since the last reported case, which was detected and isolated in Taiwan on 15 June.

WHO has warned that continued global vigilance for SARS is crucial for the foreseeable future. Scientists continue to work on a diagnostic test, needed to distinguish SARS patients from those suffering from other respiratory illnesses, particularly during the influenza season.

Milestones to SARS elimination: Travel recommendations prior to containment

2 April: Issued for Hong Kong and Guangdong Province, China.

23 April: Issued for Beijing and Shanxi Province, China, and for Toronto, Canada.

30 April: Lifted for Toronto.

8 May: Issued for Tianjin and Inner Mongolia, China, and Taipei, Taiwan.

17 May: Issued for Hebei Province, China.

21 May: Issued for all of Taiwan.

23 May: Lifted for Hong Kong and Guangdong Province,

13 June: Lifted for Heibei, Inner Mongolia, Shanxi, and Tianjin provinces, China.

17 June: Lifted for Taiwan

24 June: Lifted for Beijing - the last area on the list.


Chronology of changes in the list of areas with recent local transmission

22 March: Initial list includes Toronto, parts of mainland China, Hong Kong, Taiwan, Singapore, and Viet Nam.

11 April: Beijing added.

28 April: Viet Nam removed - becomes first country to contain its SARS outbreak.

1 May: Mongolia added.

7 May: Philippines added.

9 May: Mongolia removed.

14 May: Toronto removed.

20 May: Philippines removed.

26 May: Toronto added for second time.

31 May: Singapore removed.

13 June: Guangdong, Hebei, Hubei, Inner Mongolia, Jilin, Jiangsu, Shaanxi, Shanxi, and Tianjin (China) removed.

23 June: Hong Kong removed.

24 June: Beijing removed.

2 July: Toronto removed.

5 July: Taiwan removed.

References :
  1. WHO. Communicable Disease Surveillance and Response. Disease outbreak news: Update 96 - Taiwan, China: SARS transmission interrupted in last outbreak area, 5 July 2003. (http://www.who.int/csr/don/2003_07_05/en/print.html).
  2. WHO. SARS outbreak contained worldwide. Press release, 5 July 2003. (http://www.who.int/mediacentre/releases/2003/pr56/en/).

back to top



Back to Table of Contents
Previous

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.